baricitinib - Articles and news items

Asia-Pacific rheumatoid arthritis treatment market value will reach $7 billion by 2021, says GBI Research

Industry news / 2 June 2015 / Victoria White

The rheumatoid arthritis therapeutics market in the APAC region will expand in value from $5.6 billion in 2014 to an estimated $7 billion by 2021…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+